OR WAIT null SECS
January 17, 2019
Lonza and Takeda have furthered their multiproduct partnership through collaborative efforts on a new cancer treatment-Alunbrig (brigatinib).
November 02, 2018
As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.
October 02, 2018
Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.
September 02, 2018
Single-use technologies, modular systems, and robots are on the rise.
August 20, 2018
The acquisition of Juniper expands and strengthens Catalent’s offerings in formulation development, bioavailability solutions, and clinical-scale oral dose manufacturing.
August 03, 2018
The companies will collaborate to bring InnoCore Pharmaceuticals’ proprietary SynBiosys biodegradable polymer platform to market.
July 02, 2018
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
June 01, 2018
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
May 15, 2018
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 07, 2018
Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.